Soricimed Makes 'Shrew'd Play in Cancer Treatment, Diagnosis
Drugs derived from the venom of unusual species is hardly a novelty in biotech. There's Amylin Pharmaceuticals Inc.'s Gila monster-derived diabetes drug Byetta (exenatide) and investigational drugs GxMTx4, a nontoxic peptide from spider venom from Rose Pharmaceuticals for Duchenne's muscular dystrophy, and Paion AG's recently divested desmoteplase, a plasminogen activator based on the saliva from a vampire bat.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter